Haemonetics EBIT Margin 2010-2024 | HAE
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Haemonetics (HAE) over the last 10 years. The current EBIT profit margin for Haemonetics as of December 31, 2024 is .
| Haemonetics EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2024-12-31 | $1.37B | $0.18B | 13.17% |
| 2024-09-30 | $1.36B | $0.17B | 12.34% |
| 2024-06-30 | $1.33B | $0.15B | 11.33% |
| 2024-03-31 | $1.31B | $0.17B | 12.61% |
| 2023-12-31 | $1.27B | $0.17B | 13.40% |
| 2023-09-30 | $1.24B | $0.17B | 13.49% |
| 2023-06-30 | $1.22B | $0.18B | 14.71% |
| 2023-03-31 | $1.17B | $0.16B | 13.37% |
| 2022-12-31 | $1.13B | $0.14B | 12.41% |
| 2022-09-30 | $1.08B | $0.13B | 12.28% |
| 2022-06-30 | $1.03B | $0.11B | 10.82% |
| 2022-03-31 | $0.99B | $0.08B | 8.15% |
| 2021-12-31 | $0.95B | $0.04B | 4.30% |
| 2021-09-30 | $0.93B | $0.05B | 4.82% |
| 2021-06-30 | $0.90B | $0.08B | 8.75% |
| 2021-03-31 | $0.87B | $0.09B | 10.34% |
| 2020-12-31 | $0.88B | $0.14B | 15.52% |
| 2020-09-30 | $0.90B | $0.14B | 15.30% |
| 2020-06-30 | $0.95B | $0.13B | 13.64% |
| 2020-03-31 | $0.99B | $0.10B | 10.53% |
| 2019-12-31 | $1.00B | $0.10B | 10.21% |
| 2019-09-30 | $0.99B | $0.09B | 9.02% |
| 2019-06-30 | $0.98B | $0.07B | 6.66% |
| 2019-03-31 | $0.97B | $0.08B | 8.58% |
| 2018-12-31 | $0.95B | $0.07B | 7.67% |
| 2018-09-30 | $0.94B | $0.05B | 4.90% |
| 2018-06-30 | $0.92B | $0.04B | 4.77% |
| 2018-03-31 | $0.90B | $0.06B | 6.19% |
| 2017-12-31 | $0.90B | $-0.02B | -1.78% |
| 2017-09-30 | $0.89B | $0.00B | 0.45% |
| 2017-06-30 | $0.89B | $0.00B | 0.56% |
| 2017-03-31 | $0.89B | $-0.02B | -2.26% |
| 2016-12-31 | $0.90B | $0.03B | 3.56% |
| 2016-09-30 | $0.91B | $-0.05B | -5.52% |
| 2016-06-30 | $0.91B | $-0.06B | -6.19% |
| 2016-03-31 | $0.91B | $-0.04B | -4.85% |
| 2015-12-31 | $0.89B | $-0.03B | -2.91% |
| 2015-09-30 | $0.89B | $0.05B | 5.95% |
| 2015-06-30 | $0.90B | $0.05B | 5.12% |
| 2015-03-31 | $0.91B | $0.04B | 4.40% |
| 2014-12-31 | $0.93B | $0.04B | 4.32% |
| 2014-09-30 | $0.94B | $0.04B | 4.28% |
| 2014-06-30 | $0.94B | $0.05B | 5.41% |
| 2014-03-31 | $0.94B | $0.05B | 4.90% |
| 2013-12-31 | $0.95B | $0.05B | 5.49% |
| 2013-09-30 | $0.95B | $0.05B | 5.25% |
| 2013-06-30 | $0.94B | $0.04B | 3.96% |
| 2013-03-31 | $0.89B | $0.06B | 6.40% |
| 2012-12-31 | $0.83B | $0.06B | 7.25% |
| 2012-09-30 | $0.77B | $0.07B | 8.94% |
| 2012-06-30 | $0.73B | $0.08B | 10.64% |
| 2012-03-31 | $0.73B | $0.09B | 12.23% |
| 2011-12-31 | $0.71B | $0.10B | 13.64% |
| 2011-09-30 | $0.70B | $0.10B | 14.49% |
| 2011-06-30 | $0.69B | $0.11B | 16.20% |
| 2011-03-31 | $0.68B | $0.11B | 16.40% |
| 2010-12-31 | $0.68B | $0.09B | 12.72% |
| 2010-09-30 | $0.66B | $0.08B | 12.50% |
| 2010-06-30 | $0.65B | $0.08B | 12.39% |
| 2010-03-31 | $0.65B | $0.08B | 12.87% |
| 2009-12-31 | $0.63B | $0.10B | 15.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.198B | $1.309B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.174B | 28.29 |
| Boston Scientific (BSX) | United States | $155.945B | 42.10 |
| Stryker (SYK) | United States | $148.251B | 31.87 |
| EssilorLuxottica (ESLOY) | France | $140.098B | 0.00 |
| Medtronic (MDT) | Ireland | $111.559B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.232B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.180B | 29.35 |
| GE HealthCare Technologies (GEHC) | United States | $42.309B | 20.61 |
| Agilent Technologies (A) | United States | $39.127B | 25.93 |
| ResMed (RMD) | United States | $34.442B | 26.53 |
| Terumo (TRUMY) | Japan | $26.591B | 37.81 |
| Koninklijke Philips (PHG) | Netherlands | $23.545B | 16.81 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.572B | 12.92 |
| Insulet (PODD) | United States | $19.899B | 79.24 |
| Baxter (BAX) | United States | $15.736B | 10.24 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.201B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.927B | 37.20 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.944B | 27.52 |
| Lantheus Holdings (LNTH) | United States | $5.659B | 13.15 |
| Prestige Consumer Healthcare (PBH) | United States | $4.205B | 20.07 |
| ICU Medical (ICUI) | United States | $4.019B | 38.26 |
| Envista Holdings (NVST) | United States | $3.747B | 29.81 |
| Perrigo (PRGO) | Ireland | $3.383B | 9.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.913B | 19.63 |
| QuidelOrtho (QDEL) | United States | $2.817B | 23.67 |
| LeMaitre Vascular (LMAT) | United States | $2.319B | 56.37 |
| Neogen (NEOG) | United States | $2.232B | 25.73 |
| AtriCure (ATRC) | United States | $1.907B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.89 |
| InMode (INMD) | Israel | $1.349B | 11.28 |
| BioLife Solutions (BLFS) | United States | $1.296B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.211B | 8.65 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.030B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.979B | 15.01 |
| Evolus (EOLS) | United States | $0.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.918B | 0.00 |
| CeriBell (CBLL) | United States | $0.794B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.686B | 0.00 |
| Valneva SE (VALN) | France | $0.613B | 0.00 |
| Omeros (OMER) | United States | $0.536B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.527B | 4.12 |
| Surmodics (SRDX) | United States | $0.491B | 0.00 |
| SNDL (SNDL) | Canada | $0.465B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.438B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 31.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.341B | 0.00 |
| Cerus (CERS) | United States | $0.336B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.318B | 57.90 |
| Viemed Healthcare (VMD) | United States | $0.315B | 30.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.301B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.294B | 19.70 |
| Biote (BTMD) | United States | $0.266B | 5.83 |
| Canopy Growth (CGC) | Canada | $0.260B | 0.00 |
| Zynex (ZYXI) | United States | $0.239B | 50.13 |
| Sanuwave Health (SNWV) | United States | $0.236B | 3.31 |
| Brainsway (BWAY) | Israel | $0.213B | 113.20 |
| High Tide (HITI) | Canada | $0.210B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.40 |
| MacroGenics (MGNX) | United States | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.167B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.141B | 17.65 |
| Jin Medical (ZJYL) | China | $0.122B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 13.08 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Exagen (XGN) | United States | $0.068B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.060B | 30.83 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| MariMed (MRMD) | United States | $0.052B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.049B | 14.17 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| INLIF (INLF) | $0.046B | 0.00 | |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |